← Leaderboards
Emmanuel C. Opara
Wake Forest University Health Sciences
$2,148,324
Attributed
$3,492,961
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $626K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,492,961 · 5
By mechanism
R01$2,526,205 · 2
R25$530,784 · 2
R21$435,972 · 1
Top collaborators
- Barbara D. Boyan3 shared
- Justin Saul3 shared
- Saami K Yazdani3 shared
- Leanne Groban2 shared
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- David C Sane$511,832
- Jianfeng Xu$13,367,512
- Leanne Groban$7,151,172
- Ashley Weaver$4,381,622
- Kristen Marie Beavers$7,492,384
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanEvaluationBiomedical EngineeringTissue EngineeringProgramsRattusTissuesCellsResearch PersonnelUnited States National Institutes Of HealthAnimalsStructureCohortDesignSymposiumPreventionEncapsulatedCoupledEndocrineCell TherapyEngineeringCareerDoctor Of PhilosophyAlginates
Grant awards (12)
Sustained regulation of hypothalamus-pituitary-ovary hormones with tissue-engineered ovarian constructs as a treatment for osteoporosis in females$490,107
R01 · FY2025 · AR
Tissue Engineering and Regenerative Medicine Undergraduate Research Addressing Challenges in Kidney and Urologic Diseases$107,996
R25 · FY2025 · DK · contact PI
Sustained regulation of hypothalamus-pituitary-ovary hormones with tissue-engineered ovarian constructs as a treatment for osteoporosis in females$494,133
R01 · FY2024 · AR
Tissue Engineering and Regenerative Medicine Undergraduate Research Addressing Challenges in Kidney and Urologic Diseases$107,996
R25 · FY2024 · DK · contact PI
Sustained regulation of hypothalamus-pituitary-ovary hormones with tissue-engineered ovarian constructs as a treatment for osteoporosis in females$517,962
R01 · FY2023 · AR
Tissue Engineering and Regenerative Medicine Undergraduate Research Addressing Challenges in Kidney and Urologic Diseases$107,996
R25 · FY2023 · DK · contact PI
Tissue Engineering and Regenerative Medicine Undergraduate Research Addressing Challenges in Kidney and Urologic Diseases$107,952
R25 · FY2022 · DK · contact PI
Effects of cell-based hormone therapy on LV diastolic dysfunction and hypertrophy progression after mid-life estrogen loss$203,472
R21 · FY2020 · AG
Effects of cell-based hormone therapy on LV diastolic dysfunction and hypertrophy progression after mid-life estrogen loss$232,500
R21 · FY2019 · AG
Tissue Engineering and Regenerative Medicine Undergraduate Research Addressing Challenges In Diabetes, Kidney, Urologic and Hematologic Diseases$98,844
R25 · FY2019 · DK · contact PI
Bioengineering A Bioartificial Pancreas$515,203
R01 · FY2010 · DK · contact PI
Bioengineering A Bioartificial Pancreas$508,800
R01 · FY2009 · DK · contact PI